Lentiviral gene therapy for HIV using TRIM-cyclophilin restriction factors

Explore this paper's citation graph

Summary

Delivery of TRIMCyp genes using lentiviral vectors could form the basis of an intracellular vaccination strategy against HIV-1, with TRIM21Cyp having benefits by maintaining endogenous TRIM function.

Published
2012-10-28
Cited by
0
References
420

References

Cited by

No citing papers recorded for this paper.

Related papers

No related papers recorded.